234 related articles for article (PubMed ID: 34992678)
1. Fecal microbiota transplantation for recurrent
Sandhu A; Chopra T
Therap Adv Gastroenterol; 2021; 14():17562848211053105. PubMed ID: 34992678
[No Abstract] [Full Text] [Related]
2. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
[TBL] [Abstract][Full Text] [Related]
3. Microbiota restoration therapies for recurrent
DuPont HL; DuPont AW; Tillotson GS
Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
[TBL] [Abstract][Full Text] [Related]
4. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Steed DB; Wang T; Raheja D; Waldman AD; Babiker A; Dhere T; Kraft CS; Woodworth MH
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055258
[TBL] [Abstract][Full Text] [Related]
5. The role of the gut microbiome in colonization resistance and recurrent
Seekatz AM; Safdar N; Khanna S
Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
[TBL] [Abstract][Full Text] [Related]
6. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
Madoff SE; Urquiaga M; Alonso CD; Kelly CP
Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Recurrent
Azimirad M; Yadegar A; Gholami F; Shahrokh S; Asadzadeh Aghdaei H; Ianiro G; Suzuki H; Cammarota G; Zali MR
J Inflamm Res; 2020; 13():563-570. PubMed ID: 32982371
[TBL] [Abstract][Full Text] [Related]
11. Safety of fecal microbiota transplantation for
Yadav D; Khanna S
Therap Adv Gastroenterol; 2021; 14():17562848211009694. PubMed ID: 33959193
[No Abstract] [Full Text] [Related]
12. Fecal microbiota transplantation for treatment of refractory or recurrent
Lan KY; Le PH; Chiu CT; Chen CC; Yeh YM; Cheng HT; Kuo CJ; Chen CL; Chen YC; Yeh PJ; Chiu CH; Chang CJ
Front Med (Lausanne); 2023; 10():1229148. PubMed ID: 37849493
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
Girotra M; Garg S; Anand R; Song Y; Dutta SK
Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
[TBL] [Abstract][Full Text] [Related]
14. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
15. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
16. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
17. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
[TBL] [Abstract][Full Text] [Related]
18. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials.
Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR
J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L
Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]